Morbi-Mortalidad en pacientes obesos infectados por COVID-19
The Covid-19 pandemic has revolutionized all systems in the world, becoming one of the greatest challenges in the history of mankind, especially at the health level. Obesity is a major underlying condition that is associated with severe Covid-19 disease. According to figures from the World Health Or...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=7945977 |
| Source: | RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 5, Nº. 2, 2021, pags. 71-79 |
| Tags: |
Add Tag
No Tags: Be the first to tag this record
|
| id |
dialnet-ar-18-ART0001462144
|
|---|---|
| record_format |
dialnet
|
| institution |
Dialnet
|
| collection |
Dialnet AR
|
| source |
RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 5, Nº. 2, 2021, pags. 71-79
|
| language |
Spanish
|
| topic |
Morbilidad
Mortalidad Obesidad Infección Covid-19 Morbidity Mortality Obesity Infection Covid-19 |
| spellingShingle |
Morbilidad
Mortalidad Obesidad Infección Covid-19 Morbidity Mortality Obesity Infection Covid-19 Serrano Wiesner, María de los Ángeles Katiuska Fabara Pino, Thalía Vélez Vera, Andrea Jeanette Landín Ramírez, Tania Melissa Morbi-Mortalidad en pacientes obesos infectados por COVID-19 |
| description |
The Covid-19 pandemic has revolutionized all systems in the world, becoming one of the greatest challenges in the history of mankind, especially at the health level. Obesity is a major underlying condition that is associated with severe Covid-19 disease. According to figures from the World Health Organization (WHO) as a result of being overweight or obese, there are at least 2.8 million deaths each year. Obesity affects most physiological processes and modifies the functions of the body's systems. It is essential to understand in depth the effect of obesity in the development of Covid-19 to prevent or reduce morbidities and mortality. The objective of this study is to show how obesity, as an underlying disease, affects Covid-19. Likewise, some studies related to the morbidity and mortality rate of Covid-19 in obese patients are reviewed. The research model is a bibliographic documentary type review. From the studies reviewed, it was found, firstly, that the higher BMI in-creases the probability that obese patients infected with Covid-19 will develop a more serious disease, require admission to the intensive care unit and the need for ventilation. This leads to a longer hospital stay and worse prognoses. Conse-quently, and based on the evidence reviewed, obesity is a predictor of severity or severity for Covid-19 and an important predictor of mortality. Finally, patients with obesity in health care should be treated and treated as a population at high risk for Covid-19, by virtue of which, it is important to intensify contagion preventive measures, as well as specialized health care, in confirmed cases of Covid-19.
|
| format |
Article
|
| author |
Serrano Wiesner, María de los Ángeles
Katiuska Fabara Pino, Thalía Vélez Vera, Andrea Jeanette Landín Ramírez, Tania Melissa |
| author_facet |
Serrano Wiesner, María de los Ángeles
Katiuska Fabara Pino, Thalía Vélez Vera, Andrea Jeanette Landín Ramírez, Tania Melissa |
| author_sort |
Serrano Wiesner, María de los Ángeles
|
| title |
Morbi-Mortalidad en pacientes obesos infectados por COVID-19
|
| title_short |
Morbi-Mortalidad en pacientes obesos infectados por COVID-19
|
| title_full |
Morbi-Mortalidad en pacientes obesos infectados por COVID-19
|
| title_fullStr |
Morbi-Mortalidad en pacientes obesos infectados por COVID-19
|
| title_full_unstemmed |
Morbi-Mortalidad en pacientes obesos infectados por COVID-19
|
| title_sort |
morbi-mortalidad en pacientes obesos infectados por covid-19
|
| publishDate |
2021
|
| url |
https://dialnet.unirioja.es/servlet/oaiart?codigo=7945977
|
| _version_ |
1727491712013565952
|
| spelling |
dialnet-ar-18-ART00014621442022-03-15Morbi-Mortalidad en pacientes obesos infectados por COVID-19Serrano Wiesner, María de los ÁngelesKatiuska Fabara Pino, ThalíaVélez Vera, Andrea JeanetteLandín Ramírez, Tania MelissaMorbilidadMortalidadObesidadInfecciónCovid-19MorbidityMortalityObesityInfectionCovid-19The Covid-19 pandemic has revolutionized all systems in the world, becoming one of the greatest challenges in the history of mankind, especially at the health level. Obesity is a major underlying condition that is associated with severe Covid-19 disease. According to figures from the World Health Organization (WHO) as a result of being overweight or obese, there are at least 2.8 million deaths each year. Obesity affects most physiological processes and modifies the functions of the body's systems. It is essential to understand in depth the effect of obesity in the development of Covid-19 to prevent or reduce morbidities and mortality. The objective of this study is to show how obesity, as an underlying disease, affects Covid-19. Likewise, some studies related to the morbidity and mortality rate of Covid-19 in obese patients are reviewed. The research model is a bibliographic documentary type review. From the studies reviewed, it was found, firstly, that the higher BMI in-creases the probability that obese patients infected with Covid-19 will develop a more serious disease, require admission to the intensive care unit and the need for ventilation. This leads to a longer hospital stay and worse prognoses. Conse-quently, and based on the evidence reviewed, obesity is a predictor of severity or severity for Covid-19 and an important predictor of mortality. Finally, patients with obesity in health care should be treated and treated as a population at high risk for Covid-19, by virtue of which, it is important to intensify contagion preventive measures, as well as specialized health care, in confirmed cases of Covid-19.La pandemia de Covid-19 ha revolucionado todos los sistemas del mundo, convirtiéndose en uno de los mayores retos en la historia de la humanidad, sobre todo a nivel de salud. La obesidad es una patología subyacente importante que se asocia con una enfermedad de Covid-19 grave. Según las cifras de la Organización Mundial de la Salud (OMS) como con-secuencia del sobrepeso o la obesidad, se producen al menos 2,8 millones de muertes cada año. La obesidad afecta a la mayoría de los procesos fisiológicos y modifica las funciones de los sistemas del organismo. Es fundamental comprender en profundidad el efecto de la obesidad en el desarrollo del Covid-19 para prevenir o disminuir las morbilidades y la mor-talidad. El objetivo del presente estudio consiste en plasmar la forma en que la obesidad, como enfermedad subyacente, incide sobre el Covid-19. Asimismo, se revisan algunos estudios relacionados con la tasa de morbimortalidad del Covid-19 en pacientes obesos. El modelo de investigación es una revisión de tipo documental bibliográfico. De los estudios revisa-dos se encontró, en primer lugar, que a mayor IMC aumenta la probabilidad de que los pacientes obesos infectados con Covid-19 desarrollen una enfermedad más grave, requieran el ingreso a la unidad de cuidados intensivos y la necesidad de ventilación. Esto conlleva a una mayor estancia hospitalaria y peores pronósticos. En consecuencia y con base a la evidencia revisada, la obesidad es un predictor de severidad o gravedad para el Covid-19 y un importante predictor de mortalidad. Por último, los pacientes con obesidad en la atención sanitaria, deben ser considerados y tratados como una población de alto riesgo para el Covid-19, en virtud de lo cual, es importante intensificar las medidas preventivas de contagio, así como la asistencia sanitaria especializada, en casos confirmados de Covid-19.2021text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=7945977(Revista) ISSN 2588-073XRECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 5, Nº. 2, 2021, pags. 71-79spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI
|